一品红：关于全资子公司获得己酮可可碱缓释片注册证书的公告

Group 1 - The core point of the article is that Yipinhong announced the approval of a drug registration certificate for its subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., regarding the sustained-release tablet of theobromine [2] Group 2 - The approval was granted by the National Medical Products Administration [2] - The announcement was made on the evening of November 28 [2]